Clinical Trial Details
— Status: Completed
Administrative data
NCT number |
NCT06236490 |
Other study ID # |
InstSportPoland |
Secondary ID |
|
Status |
Completed |
Phase |
|
First received |
|
Last updated |
|
Start date |
June 1, 2023 |
Est. completion date |
September 30, 2023 |
Study information
Verified date |
January 2024 |
Source |
Institute of Sport - National Research Institute, Poland |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Observational
|
Clinical Trial Summary
Blood Oxygen Level Test (BOLT) was never scientifically validated. Therefore, we investigated
the association of BOLT scores with athletic performance in well-trained athletes. The study
focuses on exercise tolerance in severe and extreme intensity domains, as they provoke
significant homeostatic perturbations.
We perform Wingate Anaerobic Test and Cardiopulmonary Exercise Test, which are part of the
regular National Team athletes screening in our lab, to see if the results may be assocciated
with BOLT results.
The performance tests are used by the Speedskating National Team multiple times per year as
training monitoring and performance assessments of the athletes.
Description:
The investigated group consisted of 49 well-trained speedskaters recruited with convenience
sampling (out of 58 that volunteered to participate in the study). All the study participants
were members of the Polish National Development Team or Polish National Elite Team in either
long-track or short-track speedskating. Inclusion criteria were as follows: a valid medical
certificate for competitive speedskating, a minimum of six years of training, and no prior
exposure to respiratory or respiratory muscle training. Exclusion criteria were as follows:
any chronic medical conditions, recent acute medical conditions within the last 4 weeks,
COVID-19 infection within the last 6 months, recent stay in an altitude over 1500 meters
above sea level within the last 4 weeks, and the use of any ongoing medications. The required
sample size was calculated with G* Power (version 3.1.9.2; Germany), with effect size ƒ² =
0.35, level of significance set at α = 0.05, power (1 - β) = 0.95, and number of predictors =
1 (Linear multiple regression: Fixed model, R² deviation from zero). According to the
calculations, the required total sample size was 40 participants. In our study, 58
participants were recruited to account for possible dropouts. Finally, 49 participants
completed all the required procedures and were included in further analysis.
Three tests are used in the study:
Blood Oxygen Level Test (BOLT) was performed according to The Oxygen Advantage guidelines.
The study participants rested for 15 minutes before measuring the BOLT score. During this
time they were carefully instructed on how to perform the measurement. It was underlined that
we do not measure how long one can hold their breath, but the time it takes for the body to
react to lack of air and feel the desire to breathe. After a few normal breaths through the
nose, after the exhalation, the participants held their breath until they felt the first
definite desire to breathe or felt the first involuntary contractions of the respiratory
muscles. The first was assessed by the participants, the latter was also visually assessed by
the researchers. The nose was closed with the fingers to prevent any gas exchange. The
researchers measured the time with a Finis 3x300M stopwatch (FINIS USA, Livermore, CA, USA).
Time in seconds, to one decimal place, was noted as a BOLT score.
Wingate Anaerobic Test (WAnT) was conducted with Monark 874E Cycle Ergometer (Monark Exercise
AB, Sweden). Before WAnT, the participants performed a 5-minute warm-up with resistance
ranging from 0.8 to 1.2 W/kg. Next, the participants performed a maximal 6-second sprint,
with the resistance adjusted to 7.5% of the individual body mass. After a rest interval of 2
to 5 minutes, the participants underwent a 30-second WAnT with resistance set at 7.5% of the
individual body mass. They were instructed to attain the highest peak power output as quickly
as possible and maintain the highest power output throughout the entire duration of the test.
The participants received motivating and enthusiastic verbal support. The following indices
were measured and included in the further analysis: peak power (Ppeak), total work (TW),
WSSR. All the indices were calculated with the dedicated software (MCE 6.0, JBA Z. Staniak,
Poland) linked to the cycle ergometer.
Cardiopulmonary Exercise Testing (CPET) was performed with the Cortex Metamax B3 (Cortex
Biophysik GmbH, Leipzig, Germany), breath-by-breath method, and Cyclus II Ergometer (RBM,
Leipzig, Germany). Participants underwent an incremental ramp test, commencing at 55-70W and
incrementally increasing the load by 0.17-0.28 W·sec-1, individually adjusted for body mass.
The participants were instructed to continue the effort until total exhaustion. All the
participants fulfilled at least five out of the six maximum effort criteria as follows: 1)
respiratory exchange ratio ≥ 1.10, (2) present VO2 plateau (growth < 100 mL·min-1 in VO2
despite increased cycling power), (3) respiratory frequency ≥ 45 breaths·min-1, (4) declared
subjective exertion intensity during CPET ≥ 18 according to the Borg Scale, (5) blood lactate
concentration ≥8 mmol·L-1, (6) peak heart rate ≥ 15 beats·min-1 below predicted maximal heart
rate (HRmax) . The following indices were measured with 15 second intervals and included in
the further analysis: maximum oxygen uptake (VO2max) in mL·min-¹·kg-¹, and time from
achieving VO2max to the cessation of the test (TtC) in seconds.
All the athletes were familiarised with testing procedures, as they peformed them multiple
times before. The medical screening is performed on a testing day in the morning. All the
athletes have to undergone the medical screening.
Further, the performance test results will be used to validate BOLT test in terms of
association with athletic performance.